July 30, 2021
July 30, 2021 | Adviser News
Covid-19 today – Learn the science behind the new variants and vaccines
With Covid-19 once again front and centre for many of us in Australia, it’s understandable that you might be interested in learning more about the virus and the various vaccines that you’re hearing about in the media.
As many of you may know, one of our strategic investment partners, American Century Investments, has a unique ownership structure with The Stowers Institute for Medical Research owning more than 40% of the business. One of the great things about the partnership is the access we get to some of the research insights from the talented research teams at the Institute.
In this webinar, Alejandro Sánchez Alvarado, PhD, of the Stowers Institute for Medical Research shares insights and explores the latest vaccine developments and the virus variants that have been making headlines. Watch here: https://corporate.americancentury.com/content/corporate/en/insights/articles/news-insights/covid-19-today-new-variants-vaccines.html
Alejandro Sánchez Alvarado, PhD is Executive Director and Chief Scientific Officer at the Stowers Institute. Among his many recognitions, he is an esteemed inductee into the U.S. National Academy of Sciences.
Important information: The content of this publication are the opinions of the writer and is intended as general information only which does not take into account the personal investment objectives, financial situation or needs of any person. It is dated 24 March 2021, is given in good faith and is derived from sources believed to be accurate as at this date, which may be subject to change. It should not be considered to be a comprehensive statement on any matter and should not be relied on as such. Past performance is not a reliable indicator of future performance and should be used as a general guide only. Neither Zurich Australia Limited ABN 92 000 010 195 AFSL 232510, nor Zurich Investment Management Limited ABN 56 063 278 400 AFSL 232511 of 118 Mount Street North Sydney NSW 2060, nor any of its related entities, employees or directors (Zurich) give any warranty of reliability or accuracy nor accept any responsibility arising in any way including by reason of negligence for errors and omissions. Zurich recommends investors seek advice from appropriately qualified financial advisers. Zurich and its related entities receive remuneration such as fees, charges and premiums for the financial products which they issue. Details of these payments can be found in the relevant fund Product Disclosure Statement. No part of this document may be reproduced without prior written permission from Zurich.
Past performance is not a reliable indicator of future performance. GINN XYY9MQ.00000.SP.03. DFOY-017190-2021